Navigation Links
TripleMaster PCR System: Direct Comparison with Competitors

Lars E. Peters, Walter Gross, and Jennifer Diers
Eppendorf 5 Prime, Inc., Boulder, CO, USA This experiment was performed to compare the Eppendorf TripleMaster PCR System with the long-range PCR products of leading competitors. Eppendorf was compared to competitors T and R in genomic DNA amplification; and competitors T, R, and AB in Lambda DNA amplification. Very stringent cycling conditions were used for all products in terms of a short extension time and low number of cycles. Please note: The cycling conditions are not according to the manufacturers instructions. These conditions prove the high processivity of the TripleMaster polymerase when tested against competitor products. In order to gain the success seen with the TripleMaster system, usual cycling conditions for competitors products would require much longer extension times and many more cycles.

Experimental Setup

Genomic DNA amplification

Reactions were executed using 200 ng of commercially purchased human gDNA (Roche). Primers targeting a 24 kb region of the human tPA gene were used. Primer sequences for the 24 kb human tPA universal forward and the 24 kb reverse primers may be found in the Eppendorf TripleMaster PCR System manual. Reaction components from each manufacturer were used as follows in the concentrations presented in parentheses:

Eppendorf TripleMaster PCR System

10X Tuning Buffer (1X)
Eppendorf dNTP Mix (0.5 mM)
MgCl2 (2.4 mM)
TripleMaster (2.0 U) Competitor R 5X Reaction Buffer (1X)
Eppendorf dNTP Mix (0.5 mM)
MgCl2 (2.4 mM)
Competitor R Polymerase (2.0 U) Competitor T Samples were processed with and without DMSO
10X Reaction Buffer (1X)
Eppendorf dNTP Mix (0.5 mM)
MgCl2 (2.4 mM)
Competitor T Polymerase (2.0 U)
DMSO (2%) Fig1: 24 kb target (tPA gen) amplification from human genomic DNA Lanes 12: Eppendorf TripleMaster PCR System Lanes 34: Competitor R Lanes 56: Competitor T Lanes 78: Competitor T +2% DMSO Lane M: Lambda Hind III Marker 40 kb target amplification from Lambda DNA Lanes 1011: Eppendorf TripleMaster PCR System Lanes 1213: Competitor R Lanes 14-15: Competitor T Lanes 1617: Competitor AB Lane M: Lambda Hind III Marker Cycling parameters

Initial denaturation
93C 3 min

10 cycles:
93C 15 sec
68C 27 min

17 cycles:
93C 15 sec
68C 21 min
+ 20 sec each cycle

Lambda DNA amplification

20 ng template was used for each reaction. Primers targeting a 40 kb region of the Lambda DNA were used for all amplification reactions. Reaction components from each manufacturer were used as follows in the concentrations presented in parentheses:

Eppendorf TripleMaster PCR System

10X Tuning Buffer (1X)
Eppendorf dNTP Mix (0.5 mM)
MgCl2 (2.4 mM)
TripleMaster (2.0 U) Competitor R 5X Reaction Buffer (1X)
Eppendorf dNTP Mix (0.5 mM)
MgCl2 (2.4 mM)
Competitor R Polymerase (2.0 U) Competitor T 10X Reaction Buffer (1X)
Eppendorf dNTP Mix (0.5 mM)
MgCl2 (2.4 mM)
Competitor T Polymerase (2.0 U) Competitor AB 3.3X Reaction Buffer (1X)
Eppendorf dNTP Mix (0.5 mM)
MgCl2 (2.2 mM)
Competitor AB Polymerase (2.0 U) Cycling parameters

Initial denaturation
93C 3 min

10 cycles:
93C 15 sec
68C 21 min

8 cycles:
93C 15 sec
68C 27 min
+ 20 sec each cycle

Sample analysis

Of each sample 25% was loaded onto a 0.4% agarose gel. The gel was stained with ethidium bromide and photographed.

Results

The Eppendorf samples clearly outperform the competition. In both the amplification of genomic DNA and Lambda DNA, the Eppendorf polymerase provides consistently high yields. Although competitor R samples perform in both cases, the Eppendorf yields are higher and more consistent. Slight amplification, however minimal, can be seen in competitor T samples. The addition of DMSO does not appear to increase amplification considerably. Competitor AB samples perform poorly. Overall the Eppendorf samples are superior to all competitor products tested.


'"/>

Source:


Page: All 1 2 3 4

Related biology technology :

1. TripleMaster PCR System
2. TripleMaster PCR System
3. The TripleMaster PCR System for three different amplifications
4. TripleMaster and Perfect gDNA Blood Mini Kit Team Up to Amplify Long gDNA Templates
5. TripleMaster PCR SystemThe Ideal Choice for Long-Range PCR
6. Using the TripleMaster PCR System for Robust Amplification of GC-Rich DNA Templates
7. The Flexible matriXarray Chip System: A New Perspective for Probe Optimization in Gene-Expression Profiling
8. Counting Colonies or Plaques Directly from Images of Agar Plates
9. High-Efficiency Site-Directed Mutagenesis of Large Plasmid Vectors
10. Constructing Directional cDNA Libraries from Limited Amounts of RNA
11. Generate High-Quality, Directional Plasmid cDNA Libraries
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: TripleMaster PCR System Direct Comparison with Competitors

(Date:7/11/2014)... 2014 Research and Markets  has announced ... - Global Industry Analysis, Size, Share, Growth, Trends and ... http://photos.prnewswire.com/prnh/20130307/600769 Transfection ... DNA or RNA) into cells. This technology helps the ... and protein metabolism by affecting the nuclear genes. The ...
(Date:7/11/2014)... BCC Research ( http://www.bccresearch.com ) reveals in its ... TECHNOLOGY: GLOBAL MARKETS , the global market for digital ... in 2013. This is estimated to grow to $490 ... rate (CAGR) of 28.6%. , New digital PCR technology ... within the broader PCR field. The opportunities presented by ...
(Date:7/11/2014)... GENEVA , July 11, 2014 ... pleased to announce the appointment of John P. ... Campus Biotech   in  Geneva . ... on Campus Biotech in Geneva , ... internationally recognised neuroscientists. John P. Donoghue , founder ...
(Date:7/11/2014)... MISSISSAUGA, ON , July 11, 2014 /CNW/ - ... Canada approved APTIOM TM (eslicarbazepine acetate) for use ... partial-onset seizures in patients with epilepsy who are not ... not indicated for use in patients under 18 years ... the most common neurological disorders and according to Epilepsy ...
Breaking Biology Technology:International Transfection Technology Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 3John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva 2John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 2Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 4
... CARLOS, Calif., Jan. 5 Nektar Therapeutics,(Nasdaq: ... Robin, is,scheduled to present at the upcoming 27th Annual ... St. Francis Hotel on Tuesday,January 13, 2009 at 10:00 ... The presentation will be accessible via ...
... ... (PRWEB) December 17, 2008 -- Facilitating the entry of ... analyzer, now updated to effortlessly examine not only the wireless interface ... but also the interface between the device CPU and the Bluetooth ...
... /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Alternext ... identifies, develops and commercializes differentiated products for ... received clearance from Canadian regulatory authorities to ... for nimotuzumab, its EGFR-targeting antibody, in combination ...
Cached Biology Technology:Newly Available To Medical Device Manufacturers - Bluetooth Testing Equipment 2Newly Available To Medical Device Manufacturers - Bluetooth Testing Equipment 3YM BIOSCIENCES RECEIVES CLEARANCE TO INITIATE RANDOMIZED DOUBLE-BLIND CLINICAL TRIALS OF NIMOTUZUMAB IN LUNG CANCER AND BRAIN METASTASES FROM LUNG CANCER 2YM BIOSCIENCES RECEIVES CLEARANCE TO INITIATE RANDOMIZED DOUBLE-BLIND CLINICAL TRIALS OF NIMOTUZUMAB IN LUNG CANCER AND BRAIN METASTASES FROM LUNG CANCER 3YM BIOSCIENCES RECEIVES CLEARANCE TO INITIATE RANDOMIZED DOUBLE-BLIND CLINICAL TRIALS OF NIMOTUZUMAB IN LUNG CANCER AND BRAIN METASTASES FROM LUNG CANCER 4YM BIOSCIENCES RECEIVES CLEARANCE TO INITIATE RANDOMIZED DOUBLE-BLIND CLINICAL TRIALS OF NIMOTUZUMAB IN LUNG CANCER AND BRAIN METASTASES FROM LUNG CANCER 5YM BIOSCIENCES RECEIVES CLEARANCE TO INITIATE RANDOMIZED DOUBLE-BLIND CLINICAL TRIALS OF NIMOTUZUMAB IN LUNG CANCER AND BRAIN METASTASES FROM LUNG CANCER 6YM BIOSCIENCES RECEIVES CLEARANCE TO INITIATE RANDOMIZED DOUBLE-BLIND CLINICAL TRIALS OF NIMOTUZUMAB IN LUNG CANCER AND BRAIN METASTASES FROM LUNG CANCER 7
(Date:7/11/2014)... researchers at the National Institute of Standards and ... their work more effectively, they often prove that ... was the case recently for M. Lorna De ... the growing specialization of glycomics. Glycomics is the ... glycans that are attached to proteins and lipids ...
(Date:7/11/2014)... from The Chinese University of Hong Kong, BGI and ... linked to salt tolerance, with implication for improving this ... published online in Nature Communications provides an ... improvement. , Soybean is an important crop for the ... have less genetic diversities than their wild counterparts. Among ...
(Date:7/11/2014)... 3, 2014, Shenzhen, China Researchers from Salk Institute ... the first time evaluated the safety and reliability ... successfully developed a new method, TALEN-HDAdV, which could ... stem cell (hiPSC). This study published online in ... theoretical foundation for stem cell-based gene therapy. , ...
Breaking Biology News(10 mins):BGI reports a novel gene for salt tolerance found in wild soybean 2A new genome editing method brings the possibility of gene therapies closer to reality 2
... JUPITER, FL, October 26, 2010 The Scripps Research Institute ... Fox Foundation to study a pair of genetic mutations that ... for Parkinson,s disease, a progressive and fatal neurodegenerative disorder. ... director for drug discovery at Scripps Florida, is the principal ...
... the brain, which scavenge pathogens and damaged neurons, are also ... by Duke neuroscientists. Earlier studies by Staci Bilbo, an ... rats experiencing an infection at an early age have an ... learning and memory. In a study published in ...
... has a companion among emerging futuristic "e-sensing" devices intended ... is a "magnetic tongue" -- a method used to ... sweet, bitter, sour, etc. A report on use of ... Journal of Agricultural and Food Chemistry . ...
Cached Biology News:Scripps Research scientist awarded $500,000 grant to study Parkinson's disease 2Scripps Research scientist awarded $500,000 grant to study Parkinson's disease 3Source found for immune system effects on learning, memory 2Source found for immune system effects on learning, memory 3